Zuranolone (Zurzuvae)
Mental Health · GABA-A neurosteroid (positive allosteric modulator)
Tier B+
What this is
Sage Therapeutics/Biogen. First oral postpartum depression treatment (vs IV brexanolone/Zulresso 2019). 14-day course produces rapid sustained improvement. FDA declined MDD indication after Phase 3 SKYLARK and SHORELINE didn't replicate strong PPD effect — class-wide debate about whether neurosteroids are MDD-suitable. Schedule IV controlled.
Mechanism
Synthetic neurosteroid analog of allopregnanolone; positive allosteric modulator of synaptic and extrasynaptic GABA-A receptors; rapid normalization of GABAergic tone disrupted in postpartum depression
Dose & route
50 mg PO once daily x 14 days (with fat-containing meal)
Citations
- https://pubmed.ncbi.nlm.nih.gov/41520874/
- https://pubmed.ncbi.nlm.nih.gov/41139588/
- https://pubmed.ncbi.nlm.nih.gov/40859935/
Links go to the source. If a link is dead or you want something re-checked, let me know.
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.